In a highly revealing recent interview Johnson & Johnson CEO Alex Gorsky suggested that people may need to accept annual COVID-19 vaccinations in future. Outlining a scenario similar to that of seasonal flu shots, Gorsky stated that due to mutations of the virus the protective efficacy of current vaccines may only last for as little as a year before ‘booster’ or secondary jabs become necessary. With other multinational vaccine manufacturers such as Pfizer and Moderna similarly now indicating they are pushing in this strategic direction, preparations are clearly underway to coerce the world into accepting annual COVID-19 vaccinations as the norm.
Reflecting their close relationship with the drug industry, governments of the world’s major pharmaceutical investment nations have already started preparing for annual COVID-19 vaccination programs. Nadhim Zahawi, the UK government’s vaccines minister, admitted on BBC television recently that his country’s National Health Service (NHS) is planning for annual COVID-19 inoculations to take place every Autumn/Fall. The UK NHS has long had close links to the pharma industry, with an investigation in 2016 revealing that more than 130 of its officials were on drug company payrolls. The Daily Telegraph, the British newspaper that uncovered the story, described such conflicts of interest as being “systemic” within the NHS.
But vaccination via needle is far from being the only pharma COVID-19 intervention being prepared for worldwide rollout. Kate Bingham, a British venture capitalist with close links to the pharma industry who formerly led the UK government’s so-called ‘Vaccine Taskforce’, says she wants to see quicker ways established for administering coronavirus inoculations. Methods Bingham proposes include the use of vaccine skin patches, nasal sprays, and pills. Revealingly, therefore, while chairing the UK’s ‘Vaccine Taskforce’, she was accused of failing to publicly declare that she was simultaneously managing private investments in companies developing coronavirus drugs. In a somewhat clumsy attempt to defend her connections, the UK government published a statement describing Bingham as “a proven drugs discovery expert” who is “well known and highly rated by multinational pharmaceutical and vaccine companies.”
Behind the scenes, the development of all three inoculation approaches advocated by Bingham is already underway. In one example, a team from Swansea University in Wales is working on what it describes as the ‘world’s first COVID-19 smart patch vaccine’. Employing the use of microneedles to deliver a vaccine, the device is claimed to simultaneously also measure a patient’s inflammatory response to the vaccination by monitoring biomarkers in the skin. Swansea University has had close links with drug and vaccine manufacturers such as AstraZeneca, GlaxoSmithKline (GSK), and others.
Similarly, a team from Lancaster University in the UK recently announced the development of a COVID-19 nasal spray. The researchers claim their technology could provide a low-cost vaccination approach for developing countries. The team is led by Dr. Muhammad Munir, who is said to have “world leading experience” in a process capable of converting DNA into infectious viruses.
A method of delivering COVID-19 vaccines in pill form is also now in clinical trials. Developed in the UK, the worldwide rights to the technology were recently acquired by biotech company ImmunityBio. Trials are currently underway in South Africa and the United States, with talks taking place on extending them to the UK.
Based on these developments, it is clear that the pharma industry and its stakeholders view COVID-19 as a long-term business opportunity. As is also the case with other diseases, rather than seeking to bring the pandemic to an end, they see more profit potential in prolonging it.
None of the above should be taken as suggesting that our organization completely opposes all forms of vaccines. We recognize that vaccines based on peptides, short chains of the naturally occurring amino acids found in food, have potential in the prevention and control of diseases such as cancer, for example. Scientists at the Dr. Rath Research Institute in California have already published pioneering work in this area.
The fact is however that vaccines alone cannot provide a long-term solution to the COVID-19 pandemic. Instead, to chart a way out of the current global crisis, we need to look to approaches using vitamin C in combination with other micronutrients. Unlike vaccines, research shows that naturally occurring micronutrients can regulate human cell systems in such a way that they become capable of protecting themselves against all variants or mutations of the coronavirus. The failure of politicians to acknowledge the existence of this research is killing patients. It’s time to raise your voice and inform political leaders there’s a better way of doing things.